Table 2.

Adverse Events

Group	W/D due to ADEs RR (95% CI)	Headache RR (95% CI)	Nausea RR (95% CI)	Dizziness RR (95% CI)	Somnolence RR (95% CI)	Fatigue RR (95% CI)
Dopamine agonists	1.35 (1.00–1.81)a	1.20 (0.98–1.47)	3.25 (2.36–4.48)a	1.47 (1.02–2.13)a	1.94 (1.45–2.61)a	1.37 (1.01–1.86)a
Pramipexole	1.15 (0.49–2.69)	0.99 (0.64–1.54)	2.68 (1.51–4.76)a	1.03 (0.51–2.07)	1.55 (0.75–3.20)	1.09 (0.64–1.85)
Ropinirole	1.49 (1.06–2.10)a	1.21 (0.95–1.54)	3.95 (2.76–5.66)a	1.72 (1.13–2.62)a	2.03 (1.47–2.80)a	1.72 (1.18–2.68)a
Rotigotine	0.46 (0.08–2.58)	1.34 (0.54–3.33)	0.82 (0.16–4.24)	0.58 (0.19–1.73)	N/A	0.78 (0.32–1.92)
Sumanirole	1.11 (0.06–19.45)	2.68 (1.01–7.11)a	4.77 (0.65–34.69)	4.53 (0.62–33.04)	N/A	N/A

ADEs=adverse drug events; CI=confidence interval; N/A = not available; RR = relative risk; W/D = withdrawal.

^aP<.05.